Skip to main content

Table 3 BA, height, weight, IGF-1, HbA1c and thyroid function in the fourth proband after GH treatment

From: Molecular genetic analysis and growth hormone response in patients with syndromic short stature

CA (year) BA (year) Height (cm) Weight (kg) GH (IU/kg/d) IGF-1 ng/mL HbA1c (3.6–6.0%) INS (2.6–11.8 µU/mL) FT3 (pmol/L) FT4 (pmol/L) TSH (mIU/L) Levothyroxine (µg)
12–9/12 13.5 139.3 (− 2.69SD) 30.4 (− 2.30SD) 0.15 259 (143–693) 5.2 6.9 6.3 (3.5–7.7) 15.3 (12.0–22.0) 4.19 (0.27–4.20)  
13–1/12   140.2 (− 2.73SD) 33.4 (− 1.88SD) 0.15 361 (183–850) 5.2 10.0 6.4 (3.5–7.7) 12.3 (12.0–22.0) 6.39↑ (0.27–4.20)  
13–7/12 14.5 144.0 (− 2.38SD) 34.3 (− 2.04SD) 0.16 503 (183–850) 5.2 6.6 8.0 (3.5–7.7) 15.4 (12.0–22.0) 7.07↑ (0.27–4.20) 25
13–11/12   145.0 (− 2.36SD) 38.5 (− 1.43SD)